DiviDrip · QURE

QURE — uniQure N.V.

QURE is uniQure N.V. (Healthcare) — a non-dividend-paying stock. Trading at $44.86. Market cap: $3.21B. Capital Quality Rank: 16/100 — Capital destroyer.

Stock snapshot

Price$44.86
Market cap$3.21B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)16 / 100 · Capital destroyer
ROIC (TTM)-87.0%
Revenue CAGR (3y)-46.7%
Shareholder buyback yield-15.40%
Altman Z-score zoneDistress

About QURE

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Listed2014Employees221HQAmsterdamSectorHealthcareWebsiteuniqure.com

Related non-dividend companies

Other non-dividend stocks investors research alongside QURE. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is QURE's current stock price?

QURE (uniQure N.V.) is currently trading at $44.86.

Does QURE pay a dividend?

QURE (uniQure N.V.) does not currently pay a regular dividend.

What is QURE's Capital Quality Rank?

QURE has a Capital Quality Rank of 16/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track QURE in DiviDrip

Add QURE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow